LeMaitre Vascular ROA 2007-2020 | LMAT
Current and historical return on assets (ROA) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. LeMaitre Vascular ROA for the three months ending June 30, 2020 was 8.25%.
| LeMaitre Vascular ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2020-06-30 | $0.02B | $0.26B | 8.51% |
| 2020-03-31 | $0.02B | $0.19B | 10.20% |
| 2019-12-31 | $0.02B | $0.19B | 11.16% |
| 2019-09-30 | $0.02B | $0.17B | 12.38% |
| 2019-06-30 | $0.02B | $0.16B | 12.26% |
| 2019-03-31 | $0.02B | $0.16B | 15.49% |
| 2018-12-31 | $0.02B | $0.15B | 16.34% |
| 2018-09-30 | $0.02B | $0.14B | 15.67% |
| 2018-06-30 | $0.02B | $0.14B | 17.15% |
| 2018-03-31 | $0.02B | $0.13B | 14.75% |
| 2017-12-31 | $0.02B | $0.13B | 14.59% |
| 2017-09-30 | $0.02B | $0.12B | 14.48% |
| 2017-06-30 | $0.01B | $0.11B | 13.27% |
| 2017-03-31 | $0.01B | $0.11B | 11.82% |
| 2016-12-31 | $0.01B | $0.10B | 11.22% |
| 2016-09-30 | $0.01B | $0.10B | 11.55% |
| 2016-06-30 | $0.01B | $0.10B | 10.90% |
| 2016-03-31 | $0.01B | $0.09B | 10.17% |
| 2015-12-31 | $0.01B | $0.09B | 9.38% |
| 2015-09-30 | $0.01B | $0.09B | 8.46% |
| 2015-06-30 | $0.01B | $0.08B | 7.32% |
| 2015-03-31 | $0.01B | $0.08B | 6.13% |
| 2014-12-31 | $0.00B | $0.08B | 5.08% |
| 2014-09-30 | $0.00B | $0.08B | 3.95% |
| 2014-06-30 | $0.00B | $0.08B | 4.18% |
| 2014-03-31 | $0.00B | $0.07B | 4.44% |
| 2013-12-31 | $0.00B | $0.07B | 6.06% |
| 2013-09-30 | $0.00B | $0.07B | 6.23% |
| 2013-06-30 | $0.00B | $0.06B | 6.37% |
| 2013-03-31 | $0.00B | $0.06B | 6.48% |
| 2012-12-31 | $0.00B | $0.06B | 4.94% |
| 2012-09-30 | $0.00B | $0.06B | 3.33% |
| 2012-06-30 | $0.00B | $0.06B | 3.31% |
| 2012-03-31 | $0.00B | $0.06B | 3.28% |
| 2011-12-31 | $0.00B | $0.06B | 3.25% |
| 2011-09-30 | $0.00B | $0.06B | 6.43% |
| 2011-06-30 | $0.01B | $0.06B | 8.10% |
| 2011-03-31 | $0.01B | $0.06B | 9.88% |
| 2010-12-31 | $0.01B | $0.06B | 11.72% |
| 2010-09-30 | $0.01B | $0.06B | 10.30% |
| 2010-06-30 | $0.01B | $0.06B | 8.77% |
| 2010-03-31 | $0.00B | $0.06B | 7.14% |
| 2009-12-31 | $0.00B | $0.06B | 1.83% |
| 2009-09-30 | $0.00B | $0.06B | 0.00% |
| 2009-06-30 | $-0.00B | $0.05B | -1.88% |
| 2009-03-31 | $-0.00B | $0.05B | -5.58% |
| 2008-12-31 | $-0.00B | $0.05B | -7.24% |
| 2008-09-30 | $-0.01B | $0.05B | -8.77% |
| 2008-06-30 | $-0.01B | $0.06B | -10.39% |
| 2008-03-31 | $-0.01B | $0.06B | -8.66% |
| 2007-12-31 | $-0.00B | $0.06B | -5.22% |
| 2007-06-30 | $-0.00B | $0.06B | -4.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.595B | $0.117B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.761B | 33.20 |
| Medtronic (MDT) | Ireland | $129.154B | 20.98 |
| Stryker (SYK) | United States | $70.955B | 27.51 |
| Boston Scientific (BSX) | United States | $51.986B | 30.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.178B | 0.00 |
| Baxter (BAX) | United States | $41.045B | 25.10 |
| Terumo (TRUMY) | Japan | $29.530B | 37.75 |
| ResMed (RMD) | United States | $29.334B | 46.29 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.492B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.965B | 22.45 |
| Sunny Optical Technology (SNPTF) | China | $20.566B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.585B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.620B | 70.72 |
| Insulet (PODD) | United States | $13.019B | 1289.81 |
| Quidel (QDEL) | United States | $12.525B | 66.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.849B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| Perrigo (PRGO) | Ireland | $7.514B | 13.44 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.165B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.311B | 15.66 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.203B | 0.00 |
| Neogen (NEOG) | United States | $4.135B | 69.10 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.995B | 0.00 |
| Haemonetics (HAE) | United States | $3.842B | 25.80 |
| ICU Medical (ICUI) | United States | $3.834B | 27.97 |
| Envista Holdings (NVST) | United States | $3.641B | 24.83 |
| Abcam (ABCZY) | $3.406B | 0.00 | |
| Agios Pharmaceuticals (AGIO) | United States | $3.048B | 0.00 |
| NuVasive (NUVA) | United States | $2.754B | 38.38 |
| National Vision Holdings (EYE) | United States | $2.703B | 46.76 |
| TG Therapeutics (TGTX) | United States | $2.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.706B | 157.08 |
| MacroGenics (MGNX) | United States | $1.438B | 0.00 |
| Aphria (APHA) | Canada | $1.408B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.239B | 0.00 |
| Cerus (CERS) | United States | $1.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.197B | 241.13 |
| Vapotherm (VAPO) | United States | $1.124B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.091B | 41.06 |
| Cardiovascular Systems (CSII) | United States | $1.086B | 0.00 |
| PetIQ (PETQ) | United States | $1.062B | 30.68 |
| InMode (INMD) | Israel | $1.053B | 22.24 |
| Owens & Minor (OMI) | United States | $1.047B | 23.74 |
| Phibro Animal Health (PAHC) | United States | $0.951B | 18.96 |
| Quanterix (QTRX) | United States | $0.934B | 0.00 |
| Omeros (OMER) | United States | $0.714B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.670B | 190.82 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.659B | 47.18 |
| Surmodics (SRDX) | United States | $0.640B | 77.15 |
| VAREX IMAGING (VREX) | United States | $0.636B | 15.80 |
| Zynex (ZYXI) | United States | $0.626B | 54.70 |
| Lantheus Holdings (LNTH) | United States | $0.503B | 11.72 |
| Viemed Healthcare (VMD) | United States | $0.434B | 38.48 |
| Cytosorbents (CTSO) | United States | $0.341B | 0.00 |
| HEXO (HEXO) | $0.338B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.331B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.295B | 25.33 |
| InfuSystems Holdings (INFU) | United States | $0.256B | 141.56 |
| Organigram Holdings (OGI) | Canada | $0.228B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.177B | 0.00 |
| Bovie Medical (APYX) | United States | $0.168B | 0.00 |
| Fonar (FONR) | United States | $0.161B | 14.24 |
| Surface Oncology (SURF) | United States | $0.159B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.149B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.128B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.126B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.124B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.115B | 0.00 |
| Evolus (EOLS) | United States | $0.106B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.089B | 0.00 |
| Nephros (NEPH) | United States | $0.076B | 0.00 |
| United-Guardian (UG) | United States | $0.072B | 16.78 |
| Brainsway (BWAY) | Israel | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.031B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.028B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
